Rekombinanter CD258 (Quisovalimab Biosimilar) Antikörper (Biotin)
Kurzübersicht für Rekombinanter CD258 (Quisovalimab Biosimilar) Antikörper (Biotin) (ABIN7829000)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Verwendungszweck
- Biotinylated Anti-LIGHT(quisovalimab biosimilar) mAb
-
Isotyp
- IgG4
-
-
-
-
Kommentare
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Haltbarkeit
- 12 months
-
-
- CD258 (Quisovalimab Biosimilar)
-
Andere Bezeichnung
- Quisovalimab Biosimilar
-
Substanzklasse
- Biosimilar
-
Hintergrund
-
Synonyms Target:LTg,CD258,HVEML,LIGHT,TNFSF14
Synonyms Antibody:AEVI-002,AEVI002,AEVI 002,AEVI-2,AEVI2,AEVI 2,AVTX-002,AVTX002,AVTX 002,AVTX-2,AVTX2,AVTX 2,CERC 002,CERC-002,CERC002,CERC 2,CERC-2,CERC2,MDGN-002,MDGN002,MDGN 002,MDGN 2,MDGN-2,MDGN2,SAR 252067,SAR252067,SAR-252067 -
UniProt
- O43557
Target
-